Who Is Sigyn Therapeutics?
Sigyn Therapeutics is a medical technology company headquartered in San Diego, California USA. We were established on the belief that blood purification devices can be designed to address significant unmet needs in global health.
A Therapeutic Candidate to Treat a Broad-Spectrum of Pathogen Related Conditions
To address unmet needs in global health, we created Sigyn Therapy, a dual-function blood purification technology that extracts pathogen sources of life-threatening inflammation in concert with the broad-spectrum elimination of inflammatory mediators that fuel sepsis, the #1 cause of hospital deaths worldwide.
An Expansive Pipeline of Therapeutic Opportunities
Our pathogen-related opportunities include but are not limited to the treatment of emerging bioterror and pandemic threats, drug-resistant pathogens (including antibiotic-resistant bacterial infections), hepatic encephalopathy and community-acquired pneumonia (CAP). CAP is the leading cause of death among infectious diseases, the leading cause of death in children under 5 years of age, and a catalyst for ~50% of sepsis and septic shock cases.
50+ Years of Relevant Industry Experience
Our co-founders Jim Joyce and Craig Roberts have 50+ years of combined experience in the medical technology field. Additionally, Mr. Joyce has two decades of public company CEO and Corporate Board leadership experience.